Correlation Between Candel Therapeutics and Prologis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Prologis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Prologis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Prologis, you can compare the effects of market volatilities on Candel Therapeutics and Prologis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Prologis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Prologis.

Diversification Opportunities for Candel Therapeutics and Prologis

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Candel and Prologis is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Prologis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prologis and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Prologis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prologis has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Prologis go up and down completely randomly.

Pair Corralation between Candel Therapeutics and Prologis

Given the investment horizon of 90 days Candel Therapeutics is expected to generate 3.93 times more return on investment than Prologis. However, Candel Therapeutics is 3.93 times more volatile than Prologis. It trades about 0.02 of its potential returns per unit of risk. Prologis is currently generating about 0.03 per unit of risk. If you would invest  959.00  in Candel Therapeutics on November 3, 2024 and sell it today you would lose (252.00) from holding Candel Therapeutics or give up 26.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy97.31%
ValuesDaily Returns

Candel Therapeutics  vs.  Prologis

 Performance 
       Timeline  
Candel Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Candel Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Candel Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.
Prologis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prologis has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Prologis is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Candel Therapeutics and Prologis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Candel Therapeutics and Prologis

The main advantage of trading using opposite Candel Therapeutics and Prologis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Prologis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prologis will offset losses from the drop in Prologis' long position.
The idea behind Candel Therapeutics and Prologis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stocks Directory
Find actively traded stocks across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance